Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.513EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.498EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.184EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.187EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.342EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.511EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.499.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.393EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.526EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.279EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.365EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.252EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.223EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used